Crick and Imperial researchers have found that a key antibiotic widely used to treat drug-resistant tuberculosis does not work as expected—a finding which could be used to develop new drugs. The study was part-funded by the Francis Crick Institute and the Wellcome Trust.
Click here for original story, Dr. Jekyll and Mr. Hyde: Enzyme targeted by TB antibiotic later stops the drug destroying it
Source: Phys.org